Contents

Current Cancer Drug Targets, Volume 1 - Number 2

Selectively Replicating Adenoviruses for Oncolytic Therapy

, 1(2): 85 - 107

Tack-Kee Laurent Yoon, Toshiaki Shichinohe, Sylvie Laquerre and Noriyuki Kasahara


DOI: 10.2174/1568009013334223




Selective Destruction of Tumor Cells through Specific Inhibition of Products Resulting from Chromosomal Translocations

, 1(2): 109 - 119

A. Rodriguez-Garcia, M. Sanchez-Martin, J. Perez-Losada, P. A. Perez-Mancera, A. Sagrera-Aparisi, N. Gutierrez-Cianca, C. Cobaleda and I. Sanchez-Garcia


DOI: 10.2174/1568009013334214




Mutant Cell Surface Receptors as Targets for Individualized Cancer Diagnosis and Therapy

, 1(2): 121 - 128

Karl-Friedrich Becker and Heinz Hofler


DOI: 10.2174/1568009013334205




Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents

, 1(2): 129 - 140

Sutapa Ghosh, Xing-Ping Liu, Yaguo Zheng and Fatih M. Uckun


DOI: 10.2174/1568009013334188




Thymidine Phosphorylase: A Two-Face Janus in Anticancer Chemotherapy

, 1(2): 141 - 153

F. Focher and S. Spadari


DOI: 10.2174/1568009013334232




Microarrays: Spotlight on Gene Function and Pharmacogenomics

, 1(2): 155 - 175

M. Nees and C. D. Woodworth


DOI: 10.2174/1568009013334197




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science